RT Journal Article
SR Electronic
T1 The Role Of Serum Electrolyte Level In Stroke Prognosis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.07.24.22277969
DO 10.1101/2022.07.24.22277969
A1 Onjal Taywade
A1 Neeta Chourasiya
A1 Monali Hiwarkar
A1 Anup Nillawar
YR 2022
UL http://medrxiv.org/content/early/2022/07/25/2022.07.24.22277969.abstract
AB Background and introduction Acute stroke is one of the common medical emergencies in India that contribute to mortality as well as morbidity. NIHSS scale is still the best clinical conglomerate for initial evaluation of stroke, while Modified Rankin scale performed at 3 months is a simple scale to gauge long-term neurological deficit. Hyponatremia is a common accompanying electrolyte disturbance with short as well as long-term implications in stroke.Aim and objectives With this background, a study with the following objectives was planned: 1. To estimate the incidence of electrolyte disturbance in acute ischemic stroke, 2. To determine the association of electrolyte disturbances with clinical assessment scales like NIHSS scale, ASPECT score, and MRS-3-month score.Material and Methods A prospective observational study was conducted on forty-five patients presenting with acute ischemic stroke diagnosed on imaging studies and evaluated for electrolytes (Na+, K+, Cl-).Results 55% patients had some or other electrolyte disturbance, hyponatremia(33%) being the most common, while hyperchloremia(15%) was the second. The NIHSS score showed better correlation with MRS score than ASPECT score or electrolyte disturbances.Conclusion Hyponatremia was found to be the most common electrolyte disturbance in acute ischemic stroke. This study attempted to underscore the role of electrolyte disturbance in the prognostication of acute stroke. As electrolyte measurement is feasible in low resource settings; its relevance and utility are even more pronounced.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institutional Ethics Committee, Pacific Medical College and Hospital, Udaipur, India.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors